| ²é¿´: 836 | »Ø¸´: 4 | ||
| ±¾Ìû²úÉú 1 ¸ö ²©Ñ§EPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||
dawndarkͳæ (³õÈëÎÄ̳)
|
[ÇóÖú]
ÇóÖúÓйذ¢ÎôÂåΤ¾§Ð͵ÄÎÊÌâ
|
|
| ¸ßÊÖÃÇÓÐËÄܰïæ²é²é¹ØÓÚ°¢ÎôÂåΤµÄ¾§ÐÍô£¿¶¼ÓÐÄļ¸ÖÖ¾§ÐÍ£¿ÎïÀíÐÔÖÊ·½Ãæ¶¼ÓÐÄÄÐ©Çø±ð£¿Ð»Ð»£¡ |
» ²ÂÄãϲ»¶
Äϲý´óѧ²ÄÁÏר˶311·ÖÇóµ÷¼Á
ÒѾÓÐ8È˻ظ´
°²»Õ´óѧר˶ÉúÎïÓëҽҩרҵ(086000)324·Ö£¬Ó¢ÓïÒѹýËÄÁù¼¶£¬Áù¼¶521£¬Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
292Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
085600²ÄÁÏÓ뻯¹¤306
ÒѾÓÐ10È˻ظ´
359Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
²ÄÁÏÓ뻯¹¤¿¼Ñе÷¼Á
ÒѾÓÐ11È˻ظ´
²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
²ÄÁÏѧ˶£¬Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
²ÄÁÏ292µ÷¼Á
ÒѾÓÐ9È˻ظ´
dawndark
ͳæ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 130
- Ìû×Ó: 19
- ÔÚÏß: 23.5Сʱ
- ³æºÅ: 571559
- ×¢²á: 2008-06-10
- רҵ: ºÏ³ÉÒ©Îﻯѧ
5Â¥2012-02-08 14:44:23
hblgczy
ÖÁ×ðľ³æ (ÎÄ̳¾«Ó¢)
- ²©Ñ§EPI: 667
- Ó¦Öú: 81 (³õÖÐÉú)
- ½ð±Ò: 26583.8
- É¢½ð: 168
- ºì»¨: 37
- ɳ·¢: 38
- Ìû×Ó: 11563
- ÔÚÏß: 1274Сʱ
- ³æºÅ: 348922
- ×¢²á: 2007-04-19
- ÐÔ±ð: GG
- רҵ: µç»¯Ñ§

2Â¥2012-02-07 23:22:06
³ÕÒÄ×ÓÆ¤
°æÖ÷ (ÎÄ̳¾«Ó¢)
ÀÏÆ¦
- ²©Ñ§EPI: 105
- Ó¦Öú: 2016 (½²Ê¦)
- ¹ó±ö: 5.368
- ½ð±Ò: 54487.3
- É¢½ð: 41688
- ºì»¨: 303
- ɳ·¢: 1206
- Ìû×Ó: 32611
- ÔÚÏß: 4303.7Сʱ
- ³æºÅ: 674536
- ×¢²á: 2008-12-14
- ÐÔ±ð: GG
- רҵ: ÎÞÉñÂÛ
- ¹ÜϽ: ÈËÎÄÉç¿Æ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
Title: Valacyclovir CAS Registry Number: 124832-26-4 CAS Name: L-Valine 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester Additional Names: L-valine ester with 9-[(2-hydroxyethoxy)methyl]guanine; valaciclovir; ValACV Molecular Formula: C13H20N6O4 Molecular Weight: 324.34 Percent Composition: C 48.14%, H 6.22%, N 25.91%, O 19.73% Literature References: L-Valine ester prodrug of acyclovir, q.v. Prepn: T. A. Krenitsky et al., EP 308065; L. M. Beauchamp, US 4957924 (1989, 1990 both to Wellcome). Evaluation as prodrug: L. M. Beauchamp et al., Antiviral Chem. Chemother. 3, 157 (1992). Clinical pharmacokinetics: S. Weller et al., Clin. Pharmacol. Ther. 54, 595 (1993). Review of pharmacology and clinical efficacy in herpes virus infections: C. M. Perry, D. Faulds, Drugs 52, 754-772 (1996). Clinical trial to prevent cytomegalovirus disease in renal transplantation: D. Lowance et al., N. Engl. J. Med. 340, 1462 (1999); to prevent transmission of genital herpes: L. Corey et al., ibid. 350, 11 (2004). Derivative Type: Hydrochloride CAS Registry Number: 124832-27-5 Manufacturers' Codes: 256U; BW-256U87; BW-256 Trademarks: Valtrex (GSK) Properties: Crystalline solid, occurs as hydrate. uv max (water): 252.8 nm (e 8530). Soly in water: 174 mg/ml. Absorption maximum: uv max (water): 252.8 nm (e 8530) |

3Â¥2012-02-08 08:09:42














»Ø¸´´ËÂ¥